| Needs review |
| Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women |
| A case report of malignant primary pericardial mesothelioma with atypical imaging appearance: multimodality imaging with histopathological correlation |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1/Signature 1 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1/Signature 2 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2/Signature 1 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2/Signature 2 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3/Signature 1 |
| A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3/Signature 2 |
| A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma/Experiment 1/Signature 1 |
| A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma/Experiment 1/Signature 2 |
| Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 1/Signature 1 |
| Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 2/Signature 1 |
| Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 2/Signature 2 |
| Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 3 |
| Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 3/Signature 1 |
| Alteration of the gut microbiota profile in children with autism spectrum disorder in China |
| Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1 |
| Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1/Signature 1 |
| Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1/Signature 2 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 1/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 2 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 2/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 3 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 3/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 4 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 4/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 5 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 5/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 6 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 6/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 7 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 7/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 8 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 8/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 9 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 9/Signature 1 |
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 9/Signature 2 |
| Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2/Signature 1 |
| Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2/Signature 2 |
| Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 4 |
| Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 4/Signature 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 2 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 2 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 2/Signature 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 2 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 1 |
| Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 2 |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1 |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1/Signature 1 |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1/Signature 2 |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 2 |
| Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 2/Signature 1 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 1 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 2 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 2 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 2/Signature 1 |
| Altered microbiome and metabolome profiling in fearful companion dogs: An exploratory study |
| Altered microbiome and metabolome profiling in fearful companion dogs: An exploratory study/Experiment 1 |
| Altered microbiome and metabolome profiling in fearful companion dogs: An exploratory study/Experiment 1/Signature 1 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 1 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 1/Signature 1 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 2 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 2/Signature 2 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 3 |
| Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 3/Signature 1 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1/Signature 1 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1/Signature 2 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2/Signature 1 |
| Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2/Signature 2 |
| Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2 |
| Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 1 |
| Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 2 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 1 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 1/Signature 1 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 2 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 2/Signature 1 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 1 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 2 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4/Signature 1 |
| Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4/Signature 2 |
| Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets |
| Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1 |
| Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1/Signature 1 |
| Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1/Signature 2 |
| Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals/Experiment 1/Signature 3 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 1 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 1/Signature 1 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 1/Signature 2 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 2 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 2/Signature 1 |
| Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 2/Signature 2 |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1 |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1/Signature 1 |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1/Signature 2 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1/Signature 1 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1/Signature 2 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2/Signature 1 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2/Signature 2 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3/Signature 1 |
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3/Signature 2 |
| Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes |
| Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes/Experiment 1 |
| Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes/Experiment 1/Signature 1 |
| Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes/Experiment 1/Signature 2 |
| Body site-typical microbiome signatures for children/Experiment 2 |
| Body site-typical microbiome signatures for children/Experiment 2/Signature 1 |
| Body site-typical microbiome signatures for children/Experiment 2/Signature 2 |
| Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2 |
| Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2/Signature 1 |
| Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2/Signature 2 |
| Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study |
| Changes in the gut microbiome associated with infliximab in patients with bipolar disorder |
| Changes in the gut microbiome associated with infliximab in patients with bipolar disorder/Experiment 1 |
| Changes in the Gut Microbiota of Children with Autism Spectrum Disorder |
| Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1 |
| Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1/Signature 1 |
| Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1/Signature 2 |
| Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 2 |
| Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples |
| Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples/Experiment 1 |
| Classifying dementia progression using microbial profiling of saliva |
| Classifying dementia progression using microbial profiling of saliva/Experiment 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 1/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 1/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 2/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 2/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 3 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 3/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 4 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 4/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 5 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 5/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 5/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 6 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 6/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 6/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 7 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 7/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 7/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 8 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 8/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 8/Signature 2 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 9 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 9/Signature 1 |
| Classifying dementia progression using microbial profiling of saliva/Experiment 9/Signature 2 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 1/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 2 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 2/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 3 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 3/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 4 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 4/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 5 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 5/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 6 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 6/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 7 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 7/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 8 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 8/Signature 1 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 9 |
| Comparative study of gut microbiota reveals the adaptive strategies of gibbons living in suboptimal habitats/Experiment 9/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 1/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 1/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 2/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 2/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 3 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 3/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 3/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 4 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 4/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 4/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 5 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 5/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 5/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 7 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 7/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 7/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 8 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 8/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 8/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 9 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 9/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 10 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 10/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 10/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 11 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 11/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 11/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 12 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 12/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 12/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 13 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 14 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 15 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 15/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 16 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 16/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 16/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 17 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 18 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 19 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 19/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 19/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 20 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 20/Signature 1 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 20/Signature 2 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 21 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 22 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 23 |
| Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 23/Signature 1 |
| Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study |
| Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1 |
| Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1/Signature 1 |
| Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1/Signature 2 |
| Comparison of Small Gut and Whole Gut Microbiota of First-Degree Relatives With Adult Celiac Disease Patients and Controls/Experiment 1/Signature 2 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2/Signature 1 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2/Signature 2 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3/Signature 1 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3/Signature 2 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4/Signature 1 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4/Signature 2 |
| Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease/Experiment 3/Signature 2 |
| Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma/Experiment 1 |
| Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns/Experiment 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1/Signature 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1/Signature 2 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2/Signature 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2/Signature 2 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3/Signature 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3/Signature 2 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4/Signature 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4/Signature 2 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5/Signature 1 |
| Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5/Signature 2 |
| Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 4/Signature 2 |
| Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 6/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 11 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 11/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 12 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 12/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 13 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 13/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16/Signature 2 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 1 |
| Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 3 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 3/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 13 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 13/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 14 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 14/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16/Signature 2 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 17 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 17/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18/Signature 1 |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18/Signature 2 |
| Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome |
| Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1 |
| Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1/Signature 1 |
| Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1/Signature 2 |
| Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 2/Signature 1 |
| Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 4 |
| Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway/Experiment 1/Signature 2 |
| Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease/Experiment 18/Signature 2 |
| Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans/Experiment 2/Signature 2 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1/Signature 2 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 2 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 2/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 3 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 3/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 4 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 5 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 5/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 6 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 6/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 7 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 7/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 8 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 9 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 9/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 10 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 11 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 12 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 12/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 13 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 13/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 14 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 14/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 15 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 16 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 16/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 17 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 17/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 18 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 18/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 19 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 19/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 20 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 21 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 21/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 22 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 22/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 23 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 23/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 24 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 24/Signature 1 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 25 |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 25/Signature 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 1/Signature 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 1/Signature 2 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 2 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 2/Signature 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 2/Signature 2 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 3 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 3/Signature 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 3/Signature 2 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 4 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 4/Signature 1 |
| Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes/Experiment 4/Signature 2 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 2 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 2/Signature 1 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 2/Signature 2 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 3 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 3/Signature 1 |
| Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets/Experiment 3/Signature 2 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 1 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 2 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 3 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 3/Signature 1 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 4 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 4/Signature 1 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 5 |
| Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 6 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1/Signature 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2/Signature 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3/Signature 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 4 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 4/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 4/Signature 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 5 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 5/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 6 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 6/Signature 1 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 7 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 7/Signature 1 |
| 33894293/Experiment 7/Signature 2 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 8 |
| Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 8/Signature 1 |
| 33894293/Experiment 8/Signature 2 |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1 |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1/Signature 1 |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1/Signature 2 |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 2 |
| Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 2/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 1/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 1/Signature 2 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 2 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 2/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 3 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 3/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 4 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 4/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 5 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 5/Signature 1 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 6 |
| Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 6/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 1/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 2 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 2/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 2 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 2 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 2 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 6 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 6/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 7 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 7/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 8 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 8/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 9 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 9/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 10 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 10/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 11 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 11/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 12 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 12/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 13 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 13/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 14 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 14/Signature 1 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 15 |
| Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 15/Signature 1 |
| Gut microbiome composition in the Hispanic Community Health Study/Study of Latinos is shaped by geographic relocation, environmental factors, and obesity/Experiment 5 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1/Signature 1 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1/Signature 2 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2/Signature 1 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2/Signature 2 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 3 |
| Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 3/Signature 1 |
| Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 3 |
| Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 4 |
| Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 5 |
| Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 6 |
| Gut microbiota changes in patients with autism spectrum disorders |
| Gut microbiota changes in patients with autism spectrum disorders/Experiment 1 |
| Gut microbiota changes in patients with autism spectrum disorders/Experiment 1/Signature 1 |
| Gut microbiota changes in patients with autism spectrum disorders/Experiment 1/Signature 2 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 1 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 1/Signature 1 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 2 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 2/Signature 1 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 3 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 3/Signature 1 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 4 |
| Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 4/Signature 1 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1/Signature 1 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1/Signature 2 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2/Signature 1 |
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2/Signature 2 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 1/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 1/Signature 2 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 2 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 2/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 2/Signature 2 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 3 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 3/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 4 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 4/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 5 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 5/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 6 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 6/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 7 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 7/Signature 1 |
| Gut microbiota in Parkinson’s disease patients: hospital-based study/Experiment 8 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1/Signature 1 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1/Signature 2 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2/Signature 1 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2/Signature 2 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 3 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 3/Signature 1 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4/Signature 1 |
| Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4/Signature 2 |
| Gut microbiota: impacts on gastrointestinal cancer immunotherapy/Experiment 1/Signature 2 |
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome |
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 1 |
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 1/Signature 2 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 1 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 1/Signature 1 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 2 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 2/Signature 1 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 4 |
| Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 4/Signature 1 |
| Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 12 |
| Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 12/Signature 1 |
| [[1]] |
| [[2]] |
| Human gut microbiota changes reveal the progression of glucose intolerance |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 1/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 1/Signature 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 2/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 2/Signature 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 3 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 3/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 3/Signature 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 4 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 4/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 4/Signature 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 5 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 5/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 5/Signature 2 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 6 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 6/Signature 1 |
| Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 6/Signature 2 |
| Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 2 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1/Signature 1 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1/Signature 2 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2/Signature 1 |
| Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 22 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 23 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 24 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 46 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 47 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 48 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68/Signature 2 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69/Signature 1 |
| Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69/Signature 2 |
| Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome/Experiment 1 |
| Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis/Experiment 1 |
| Influence of cigarette smoking on the human duodenal mucosa-associated microbiota |
| Influence of cigarette smoking on the human duodenal mucosa-associated microbiota/Experiment 2 |
| Integrating respiratory microbiome and host immune response through machine learning for respiratory tract infection diagnosis |
| Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer |
| Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial |
| Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 1 |
| Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 1/Signature 1 |
| Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 2 |
| Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 2/Signature 1 |
| Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients/Experiment 1 |
| Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 3 |
| Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 3/Signature 2 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1/Signature 1 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1/Signature 2 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2/Signature 1 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2/Signature 2 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 3 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 3/Signature 1 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 4 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 4/Signature 1 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 5 |
| Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 5/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5/Signature 2 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 6 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 6/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 7 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 7/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 8 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 8/Signature 1 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 9 |
| Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 9/Signature 1 |
| Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life |
| Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1 |
| Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1/Signature 1 |
| Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1/Signature 2 |
| Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study |
| Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis |
| Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1 |
| Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1/Signature 1 |
| Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1/Signature 2 |
| Linking long-term dietary patterns with gut microbial enterotypes |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1 |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1/Signature 1 |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1/Signature 2 |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2 |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2/Signature 1 |
| Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2/Signature 2 |
| Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects |
| Longitudinal and Comparative Analysis of Gut Microbiota of Tunisian Newborns According to Delivery Mode/Experiment 6/Signature 1 |
| Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1 |
| Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1/Signature 1 |
| Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1/Signature 2 |
| Lower respiratory tract microbiome composition and community interactions in smokers/Experiment 6 |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 1 |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 1/Signature 1 |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2 |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2/Signature 1 |
| Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2/Signature 2 |
| Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery/Experiment 2/Signature 1 |
| Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 2 |
| Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 3 |
| Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 4 |
| Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 1 |
| Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 2 |
| Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 3 |
| Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation/Experiment 1 |
| Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance/Experiment 1/Signature 1 |
| Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance/Experiment 1/Signature 2 |
| Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese |
| Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese |
| Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1 |
| Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1/Signature 1 |
| Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 1/Signature 1 |
| Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 1/Signature 2 |
| Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 3/Signature 1 |
| Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 3/Signature 2 |
| Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease |
| Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1 |
| Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1/Signature 1 |
| Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1/Signature 2 |
| Microbial communities associated with honey bees in Brazil and in the United States |
| Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1 |
| Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1/Signature 1 |
| Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1/Signature 2 |
| Microbiome analysis of gut microbiota in patients with colorectal polyps and healthy individuals |
| Microbiome analysis of gut microbiota in patients with colorectal polyps and healthy individuals/Experiment 1 |
| Microbiome analysis of gut microbiota in patients with colorectal polyps and healthy individuals/Experiment 1/Signature 1 |
| Microbiome analysis of gut microbiota in patients with colorectal polyps and healthy individuals/Experiment 1/Signature 2 |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 1 |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 1/Signature 3 |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2 |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2/Signature 1 |
| Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2/Signature 2 |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development/Experiment 1 |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development/Experiment 1/Signature 1 |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development/Experiment 2 |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development/Experiment 2/Signature 1 |
| Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1 |
| Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1/Signature 1 |
| Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1/Signature 2 |
| Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2 |
| Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2/Signature 1 |
| Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7/Signature 2 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8/Signature 1 |
| Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8/Signature 2 |
| Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition/Experiment 4 |
| Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis/Experiment 13/Signature 2 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 1 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 1/Signature 1 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 1/Signature 2 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 2 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 2/Signature 1 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 2/Signature 2 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 3 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 3/Signature 1 |
| Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study/Experiment 3/Signature 2 |
| Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients |
| Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1 |
| Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1/Signature 1 |
| Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1/Signature 2 |
| Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups |
| Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 1 |
| Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 2 |
| Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 3 |
| Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients |
| Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients/Experiment 1 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1/Signature 1 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1/Signature 2 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2/Signature 1 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2/Signature 2 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3/Signature 1 |
| Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3/Signature 2 |
| Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2 |
| Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2/Signature 1 |
| Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2/Signature 2 |
| Oral microbiome and obesity in a large study of low-income and African-American populations |
| Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 1 |
| Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 1/Signature 1 |
| Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2 |
| Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 1 |
| Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 5 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 5/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6/Signature 2 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7/Signature 1 |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7/Signature 2 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1/Signature 1 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1/Signature 2 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2/Signature 1 |
| Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2/Signature 2 |
| Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children |
| Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1 |
| Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1/Signature 1 |
| Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1/Signature 2 |
| Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 7/Signature 2 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1/Signature 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2/Signature 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3/Signature 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 2 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 1 |
| Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 2 |
| Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota |
| Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1 |
| Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1/Signature 1 |
| Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1/Signature 2 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 6/Signature 1 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 8/Signature 1 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 16/Signature 1 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 17/Signature 1 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 17/Signature 2 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 19/Signature 1 |
| Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 20/Signature 1 |
| Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana |
| Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1 |
| Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1/Signature 1 |
| Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1/Signature 2 |
| Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder |
| Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1 |
| Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1/Signature 1 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1/Signature 1 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1/Signature 2 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2/Signature 1 |
| Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2/Signature 2 |
| Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort |
| Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 1 |
| Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 1/Signature 1 |
| Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 2 |
| Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 2/Signature 1 |
| Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome |
| Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1 |
| Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1/Signature 1 |
| Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1/Signature 2 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1/Signature 1 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1/Signature 2 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2/Signature 1 |
| Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2/Signature 2 |
| Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection |
| Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1 |
| Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 1 |
| Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 2 |
| Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure |
| Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1 |
| Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1/Signature 1 |
| Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 6 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 6/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9/Signature 2 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10/Signature 1 |
| Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10/Signature 2 |
| Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage |
| Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1 |
| Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1/Signature 1 |
| Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1/Signature 2 |
| Protection of the Human Gut Microbiome From Antibiotics |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 1 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 2 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 2 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 2/Signature 1 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 2/Signature 2 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 3 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 1 |
| Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 2 |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1 |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1/Signature 1 |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1/Signature 2 |
| Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children |
| Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children/Experiment 1 |
| Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children/Experiment 1/Signature 1 |
| Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1 |
| Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1/Signature 1 |
| Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1/Signature 2 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1/Signature 1 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1/Signature 2 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2/Signature 1 |
| Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2/Signature 2 |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1 |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1/Signature 1 |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1/Signature 2 |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 2 |
| Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 2/Signature 1 |
| Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease/Experiment 1/Signature 2 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1/Signature 1 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1/Signature 2 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2/Signature 1 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2/Signature 2 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3/Signature 1 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3/Signature 2 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 4 |
| Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 4/Signature 1 |
| Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation |
| Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1 |
| Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1/Signature 1 |
| Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1/Signature 2 |
| Reduced microbiome alpha diversity in young patients with ADHD |
| Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1 |
| Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1/Signature 1 |
| Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1/Signature 2 |
| Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study |
| Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1 |
| Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1/Signature 1 |
| Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1/Signature 2 |
| Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease |
| Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease/Experiment 1 |
| Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1/Signature 2 |
| Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 2 |
| Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 2/Signature 1 |
| Resilience of the respiratory microbiome in controlled adult RSV challenge study |
| Resilience of the respiratory microbiome in controlled adult RSV challenge study/Experiment 1 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1/Signature 1 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1/Signature 2 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2/Signature 1 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2/Signature 2 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3/Signature 1 |
| Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3/Signature 2 |
| SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition |
| SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition/Experiment 1 |
| Shift in skin microbiota of Western European women across aging |
| Shift in skin microbiota of Western European women across aging/Experiment 1 |
| Shift in skin microbiota of Western European women across aging/Experiment 1/Signature 1 |
| Shift in skin microbiota of Western European women across aging/Experiment 1/Signature 2 |
| Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1 |
| Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1/Signature 1 |
| Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1/Signature 2 |
| Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial |
| Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1 |
| Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1/Signature 1 |
| Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1/Signature 2 |
| Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study |
| Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study/Experiment 1 |
| Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study/Experiment 1/Signature 1 |
| Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood |
| Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1 |
| Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1/Signature 1 |
| Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1/Signature 2 |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1 |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1/Signature 1 |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1/Signature 2 |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 2 |
| Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 2/Signature 1 |
| Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year |
| Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year/Experiment 1 |
| Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year/Experiment 1/Signature 1 |
| Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study |
| Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1 |
| Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1/Signature 1 |
| Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1/Signature 2 |
| Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study/Experiment 4 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 1 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 1/Signature 1 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 2 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 2/Signature 1 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 3 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 3/Signature 1 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 4 |
| Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people/Experiment 4/Signature 1 |
| Study 11 |
| Study 11/Experiment 1 |
| Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1 |
| Study 39 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 1 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 2 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 1 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3 |
| Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 1 |
| Study 84 |
| Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1 |
| Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 1 |
| Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 2 |
| Study 501 |
| Study 501/Experiment 1 |
| Study 501/Experiment 1/Signature 1 |
| Study 783 |
| Study 919/Experiment 1 |
| Study 919/Experiment 1/Signature 1 |
| Study 919/Experiment 1/Signature 2 |
| Study 984 |
| Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 1 |
| Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 1/Signature 1 |
| Study 1030 |
| Study 1098 |
| Study 1112 |
| Study 1120 |
| Study 1128 |
| Study 1134 |
| Study 1136 |
| Study 1137 |
| Study 1138 |
| Study 1153 |
| Study 1154 |
| Study 1155 |
| Study 1164 |
| Study 1171 |
| Study 1199 |
| Study 1273 |
| Study 1274 |
| Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children |
| Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1 |
| Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1/Signature 1 |
| Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1/Signature 2 |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 1 |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 1/Signature 1 |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2 |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2/Signature 1 |
| Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2/Signature 2 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3/Signature 1 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3/Signature 2 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4/Signature 1 |
| Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4/Signature 2 |
| Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease/Experiment 7 |
| Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease/Experiment 7/Signature 1 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 1 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 2 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 3 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 4 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 5 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 6 |
| Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 7 |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1 |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 1 |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 2 |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 3 |
| Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 4 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1/Signature 1 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1/Signature 2 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2/Signature 1 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2/Signature 2 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3/Signature 1 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3/Signature 2 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4/Signature 1 |
| The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4/Signature 2 |
| The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial |
| The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial/Experiment 1 |
| The conjunctival microbiome in health and trachomatous disease: a case control study/Experiment 4 |
| The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls/Experiment 2/Signature 1 |
| The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study |
| The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome |
| The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1 |
| The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1/Signature 1 |
| The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1/Signature 2 |
| The gut microbiota and metabolite profiles are altered in patients with spinal cord injury/Experiment 2/Signature 2 |
| The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 1 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1/Signature 1 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1/Signature 2 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2/Signature 1 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2/Signature 2 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3/Signature 1 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3/Signature 2 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 4 |
| The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 4/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 1/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 1/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 2/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 2/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 3 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 3/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 3/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 4 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 4/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 4/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 5 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 5/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 5/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 6 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 6/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 6/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 7 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 7/Signature 1 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 7/Signature 2 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 8 |
| The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs/Experiment 8/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 1/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 2 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 2/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 2/Signature 2 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 3 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 3/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 4 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 4/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 5 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 5/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 6 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 6/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 7 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 7/Signature 1 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 8 |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial/Experiment 8/Signature 1 |
| The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder/Experiment 4/Signature 2 |
| The nasal microbiome in asthma/Experiment 2 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 1 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 1/Signature 1 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 2 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 2/Signature 1 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 3 |
| The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 3/Signature 1 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 1 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 1/Signature 1 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 2 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 2/Signature 1 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 3 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 3/Signature 1 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 4 |
| The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 4/Signature 1 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1/Signature 1 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1/Signature 2 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2/Signature 1 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2/Signature 2 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3/Signature 1 |
| The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3/Signature 2 |
| Toward defining the autoimmune microbiome for type 1 diabetes |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 1 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 1/Signature 1 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 1/Signature 2 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 2 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 2/Signature 1 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 2/Signature 2 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 3 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 3/Signature 1 |
| Toward defining the autoimmune microbiome for type 1 diabetes/Experiment 3/Signature 2 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 1/Signature 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 2 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 2/Signature 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 3 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 3/Signature 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 4 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 4/Signature 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5/Signature 1 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5/Signature 2 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 6 |
| Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 6/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 1/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 1/Signature 2 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 2 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 2/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 2/Signature 2 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 3 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 3/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 3/Signature 2 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 4 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 4/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 4/Signature 2 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 5 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 5/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 5/Signature 3 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 6 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 6/Signature 1 |
| Unveiling the microbiome during post-partum uterine infection: a deep shotgun sequencing approach to characterize the dairy cow uterine microbiome/Experiment 6/Signature 2 |
